We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: Blood Pressure Control
MedXY News
EnglishTag

Blood Pressure Control

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Sustained Cardiovascular Benefits of Intensive Blood Pressure Management Led by Nonphysician Providers: 7-Year Follow-Up of the CRHCP Trial
CardiologyBlood Pressure Controlcardiovascular disease

Sustained Cardiovascular Benefits of Intensive Blood Pressure Management Led by Nonphysician Providers: 7-Year Follow-Up of the CRHCP Trial

By MedXY|Aug 29, 2026

Long-term intensive BP control led by trained nonphysician community providers significantly lowers cardiovascular risk over 7 years, with benefits persisting 3 years post-intervention in rural China.

Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive Review
Cardiology
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Blood Pressure Control
financial incentives

Evaluating the Clinical and Health Outcomes of Financial Incentives in Hypertension Management: A Comprehensive Review

By MedXY|Aug 18, 2026

This review synthesizes evidence on physician-focused financial incentives for hypertension control, highlighting nuanced impacts on clinical decisions, documented blood pressure control, and cardiovascular outcomes, with a focus on both ov

Mobile Health Intervention Achieves 24% Better Blood Pressure Control in Stroke Survivors: PINGS Trial Results from Ghana
CardiologyBlood Pressure ControlHypertension

Mobile Health Intervention Achieves 24% Better Blood Pressure Control in Stroke Survivors: PINGS Trial Results from Ghana

By MedXY|Apr 13, 2026

The PINGS trial demonstrates that a 12-month nurse-led mobile health intervention significantly improves blood pressure control among Ghanaian stroke survivors, with 67% achieving target BP versus 43% in usual care. This pragmatic approach

ED-Delivered Education Plus mHealth Lowers Systolic BP — TOUCHED Trial Shows a Modest but Meaningful 4.9 mm Hg Reduction at 6 Months
CardiologyBlood Pressure Controlemergency department

ED-Delivered Education Plus mHealth Lowers Systolic BP — TOUCHED Trial Shows a Modest but Meaningful 4.9 mm Hg Reduction at 6 Months

By MedXY|Dec 5, 2025

The TOUCHED randomized trial found that an ED-initiated education plus mHealth and pharmacist/APRN consultation reduced systolic blood pressure by 4.9 mm Hg at 6 months versus usual care in patients discharged with elevated BP.

Dissecting the Care Bundle: Mediation Analysis of Key Components Driving Improved Outcomes in INTERACT3 for Acute Intracerebral Hemorrhage
Clinical UpdatesBlood Pressure ControlIntracerebral Hemorrhage

Dissecting the Care Bundle: Mediation Analysis of Key Components Driving Improved Outcomes in INTERACT3 for Acute Intracerebral Hemorrhage

By MedXY|Oct 9, 2025

Mediation analysis of INTERACT3 reveals that systolic blood pressure and blood glucose control are primary drivers of functional recovery benefits in acute intracerebral hemorrhage care bundles.

Equally Effective Dual Therapy Combinations for Hypertension in Indian Patients: Insights from a Landmark Randomized Trial
CardiologyBlood Pressure Controldual therapy

Equally Effective Dual Therapy Combinations for Hypertension in Indian Patients: Insights from a Landmark Randomized Trial

By MedXY|Oct 8, 2025

This multicenter randomized trial in India shows that three dual antihypertensive combinations—amlodipine-perindopril, perindopril-indapamide, and amlodipine-indapamide—are equally effective and well-tolerated for 24-hour blood pressure con

Amiloride vs Spironolactone for Resistant Hypertension: A New Alternative Backed by Randomized Trial Evidence
CardiologyBlood Pressure ControlSpironolactone

Amiloride vs Spironolactone for Resistant Hypertension: A New Alternative Backed by Randomized Trial Evidence

By MedXY|Oct 8, 2025

A recent randomized clinical trial demonstrates amiloride’s noninferiority to spironolactone in lowering systolic blood pressure in resistant hypertension, offering a promising alternative therapy.

Baxdrostat: A Promising New Agent for Managing Uncontrolled and Resistant Hypertension
Cardiologyaldosterone synthase inhibitorBlood Pressure Control

Baxdrostat: A Promising New Agent for Managing Uncontrolled and Resistant Hypertension

By MedXY|Oct 7, 2025

Baxdrostat, a novel aldosterone synthase inhibitor, significantly reduces systolic blood pressure in patients with uncontrolled or resistant hypertension, offering a new therapeutic option with a favorable safety profile.

Balancing Benefits and Harms of Intensive Blood Pressure Control Across Cardiovascular Risk Levels
Cardiologyadverse eventsBlood Pressure Control

Balancing Benefits and Harms of Intensive Blood Pressure Control Across Cardiovascular Risk Levels

By MedXY|Oct 2, 2025

Intensive blood pressure control reduces cardiovascular events across all risk levels, with greater absolute benefits in higher-risk patients despite increased adverse events, supporting tailored treatment based on cardiovascular risk.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities